There are more than 200 different forms of primary immune deficiency diseases (PIDDs) affecting only about 500,000 people in the United States. These rare genetic diseases may be chronic, debilitating, and costly. Since the 1970s, NIAID-supported investigators have been examining the causes and complications of PIDDs to improve the lives of patients and families. NIAID aims to improve diagnosis, explore new treatments and preventions for PIDDs, and facilitate genetic counseling. It is home to the Primary Immune Deficiency Clinic, which provides diagnoses and disease management recommendations to patients and families whose lives are touched by PIDDs.
From Yeast to Humans: Basic Research Provides Insight into Rare Disease—June 22, 2015
Media Availability: NIH-Funded Researchers Identify New Genetic Immune Disorder—June 17, 2015
Media Availability: NIH Researchers Describe Spontaneous Cure of Rare Immune Disease—Feb. 5, 2015
NIAID Researchers Identify TRIANGLE Disease—Dec. 18, 2014
News From NIAID-Supported Institutions
Last Updated June 22, 2015